CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.80 -0.07 (-1.81%)
As of: Sep 29, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Enterprise Value (2018 - 2026)

Updated

CollPlant Biotechnologies' Enterprise Value was $7.55 million in the quarter ended Mar 30, 2026, down 74.1% from $29.21 million a year earlier and down 36.9% from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Enterprise Value (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Enterprise Value at CollPlant Biotechnologies came in at $11.97 million, down 58.8% from the prior year.

  • Enterprise Value has now declined for four consecutive years, with a five-year compound annual growth rate of -30.0% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Enterprise Value was $29.08 million in the year ended Dec 31, 2024 (-32.5%), $43.08 million in the year ended Dec 31, 2023 (-32.4%), $63.73 million in the year ended Dec 31, 2022 (-60.9%) and $162.84 million in the year ended Dec 31, 2021 (+127.9%).
  • Quarterly Enterprise Value has moved between $3.87 million (the quarter ended Jun 30, 2025) and $163.07 million (the quarter ended Dec 31, 2021) over five years.
  • Compared with a year earlier, Enterprise Value has declined for six straight quarters, with an average decline of 43.2% over the last eight quarters.
  • The best year-over-year quarter for Enterprise Value over five years was the quarter ended Jun 30, 2021 (growth of 146.3%); the worst was the quarter ended Jun 30, 2025 (a decline of 89.7%).
  • Per Business Quant data, CLGN's Enterprise Value in the three quarters before the quarter ended Mar 30, 2026 was $11.97 million (quarter ended Dec 31, 2025), $21.98 million (quarter ended Sep 30, 2025) and $3.87 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 CollPlant Biotechnologies 4.95 Mn 4.95 Mn -243,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 30, 2026 7.55 Mn
Dec 31, 2025 11.97 Mn
Sep 30, 2025 21.98 Mn
Jun 30, 2025 3.87 Mn
Mar 30, 2025 29.21 Mn
Dec 31, 2024 29.08 Mn
Sep 30, 2024 41.25 Mn
Jun 30, 2024 37.76 Mn
Mar 31, 2024 37.81 Mn
Dec 31, 2023 43.08 Mn
Sep 30, 2023 33.10 Mn
Jun 30, 2023 68.89 Mn
Mar 31, 2023 51.72 Mn
Dec 31, 2022 80.01 Mn
Sep 30, 2022 40.20 Mn
Jun 30, 2022 49.65 Mn
Mar 31, 2022 79.56 Mn
Dec 31, 2021 163.07 Mn
Sep 30, 2021 91.70 Mn
Jun 30, 2021 130.02 Mn
API Access

CollPlant Biotechnologies Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=CLGN&period=max&api_key=YOUR_API_KEY